SOX2 and nasopharyngeal carcinoma: The expression of SOX-2 in this study was predominantly nuclear in the tissue samples of AME and AME-hTERT lineage, as observed in nasopharyngeal carcinoma, gastric, colorectal, lung and breast cancer (Luo et al., 2013; Ren, Zhang & Ji, 2016).